2022
The Cow's Milk Related Symptom Score: The 2022 Update
VANDENPLAS, Yvan, Kateřina BAJEROVÁ, Christophe DUPONT, Philippe EIGENMANN, Mikael KUITUNEN et. al.Základní údaje
Originální název
The Cow's Milk Related Symptom Score: The 2022 Update
Autoři
VANDENPLAS, Yvan (garant), Kateřina BAJEROVÁ (203 Česká republika, domácí), Christophe DUPONT, Philippe EIGENMANN, Mikael KUITUNEN, Rosan MEYER, Carmen RIBES-KONINCKX, Silvia SALVATORE, Raanan SHAMIR a Hania SZAJEWSKA
Vydání
Nutrients, Basel, MDPI, 2022, 2072-6643
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30308 Nutrition, Dietetics
Stát vydavatele
Švýcarsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 5.900
Kód RIV
RIV/00216224:14110/22:00127377
Organizační jednotka
Lékařská fakulta
UT WoS
000823640400001
Klíčová slova anglicky
cow's milk allergy; cow's milk-related symptom score; CoMiSS; functional gastrointestinal disorder; infant feeding
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 8. 12. 2022 09:07, Mgr. Tereza Miškechová
Anotace
V originále
CoMiSS((R)) was developed 7 years ago to increase the awareness of health care professionals towards the possibility that symptoms presented by infants could be related to cow's milk. While CoMiSS was conceived mostly on theoretical concepts, data is now available from 25 clinical trials. Based on this extensive research using the tool since 2015, we aim to propose an updated CoMiSS. The evidence was reviewed, debated and discussed by 10 experts, of whom seven were part of the original group. The panel concluded that the cut-off previously proposed to indicate the likelihood that symptoms may be cow's milk related should be lowered from >= 12 to >= 10. Data in healthy infants > 6 months are missing. Since the Brussels Infant and Toddlers Stool Scale (BITSS) was recently developed for non-toilet trained children, the Bristol Stool Scale was changed to the BITSS without changing the impact of stool characteristics on CoMiSS. Overall, CoMiSS raises awareness that symptoms might be cow's milk related. New studies are needed to determine if the change in cut-off and other small adaptions improve its sensitivity and specificity. Data for CoMiSS is still needed in presumed healthy infants between 6 and 12 months old. There may also be regional differences in CoMiSS, in healthy infants as well as in those with cow's milk allergy. Finally, we emphasize that CoMiSS is an awareness tool and not a diagnostic test.